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Abstract – The heterospirocyclic 2H-azirin-3-amine (9), i.e., 
N-methyl-N-phenyl-5-thia-1-azaspiro[2.4]hept-1-en-2-amine, was prepared from 
the commercially available thiolane-3-one (10) via the corresponding 
3-carbonitrile (11) and 3-thiocarboxamide (14). This azirine reacted with 
thiobenzoic acid to give 
3-benzoylamino-N-methyl-N-phenylthiolane-3-thiocarboxamide (15). With 
N-protected valine, the protected dipeptides (16) and (17), which contain a 
heterocyclic amino acid, were obtained as mixtures of diastereoisomers. 
INTRODUCTION 
In recent years, we have shown that 2H-azirin-3-amines are useful synthons for 2,2-disubstituted glycines, 
i.e., α,α-disubstituted α-amino acids in the synthesis of conformationally restricted peptides,2–7 
cyclopeptides,8–10 and cyclodepsipeptides.11–15 A special group of α,α-disubstituted α-amino acids are 
carbo- and heterocyclic ones. Since the first isolation of the natural 
(–)-(S)-3-aminopyrrolidine-3-carboxylic acid (cucurbitin, (S)-1),16 it is of increasing interest because of its 
antihistaminic17 and antiallergic18 activities (for enantioselective syntheses, see 19,20). The analogous 
3-aminotetrahydrofuran- (2)21 and 3-aminothiolane-3-carboxylic acid (3)22 are also biologically active 
compounds (e.g., as enzyme inhibitors23). 
As carbocyclic 1-aminocarboxylic acids (e.g., 1-aminocyclopentane carboxylic acid) in peptides behave 
similar to α-aminoisobutyric acid (Aib),24 it is of interest to prepare peptides, which contain heterocyclic 
amino acids of type (1–3), and to study the influence of these amino acids on the peptide conformations. 
Because the ‘azirine/oxazolone method’2 proved to be a very convenient and efficient method for the 
coupling of sterically demanding α,α-disubstituted α-amino acids, we prepared the 2H-azirines (4–6) as 
  
 
synthons for heterocyclic α-amino acids and the 1-(2H-azirin-3-yl)prolinates (7, 8) as dipeptide 
synthons.4,25–28 All these azirines react smoothly with amino acids or peptide acids to give the 
corresponding dipeptides or extended peptide chains. 
 
 
 
In the present paper, we report the synthesis of racemic 
N-methyl-N-phenyl-5-thia-1-azaspiro[2.4]hept-1-en-2-amine (9) as a synthon for 
3-aminothiolane-3-carboxylic acid (3, Atc), a homocysteine analogue. 
 
RESULTS AND DISCUSSION 
The commercially available thiolane-3-one (10) was chosen as the starting material for the synthesis of 9. 
We intended to transform 10 into the carbonitrile (11) by using tosylmethyl isocyanide (Tosmic) as the 
reagent according to ref.29 This method has previously been used in the synthesis of 5 (X = S).25 
Unfortunately, the yield in the case of 10 → 11 was unsatisfactory (< 20%) and, therefore, the three-step 
procedure via reduction to thiolane-3-ol, tosylation, and substitution with sodium cyanide in DMSO was 
used, leading to 11 in 45% yield (Scheme 1).30 The basic hydrolysis of 11 gave thiolane-3-carboxylic acid 
(12) in 98% yield, and the amide (13) was obtained in 83% yield via DCC coupling with N-methylaniline in 
the presence of 4-(dimethylamino)pyridine (DMAP). As it was known that amides of type (13) often react 
only sluggishly with phosgene,2 13 was transformed into the corresponding thioamide (14, 96% yield) by 
treatment with Lawesson reagent in boiling toluene (cf. ref.26). Then, the desired azirine (9) was prepared 
N
H
COOH
NH2
O
COOH
NH2
S
COOH
NH2
1 2 3
X
N
N(Me)Ph
N
N(Me)Ph
N
NBoc
N(Me)Ph
O
44 5 (X = O, S, NBoc)25 626
X
N
N
7 (X = O, S)27,28
N
N
O
826
CO2Me CO2Me
 according to a modified protocol32 of the azirine synthesis of Rens and Ghosez.33 Subsequent treatment of a 
solution of 14 in dichloromethane with phosgene in toluene and catalytic amounts of DMF, change of the 
solvent to THF and addition of 1,4-diazabicyclo]2.2.2]octane (DABCO), and reaction of the intermediate 
α-chloroenamine in a mixture of DMF and THF with sodium azide yielded 9 (Scheme 1). After 
chromatographic workup, the azirine (9) was obtained in 70% yield, contaminated with small amounts (≤ 
5%) of the amide (13).34 As this amide does not interfere with the forthcoming reactions, we avoided the 
tedious and loss-making separation of 9 and 13. 
 
Scheme  1 
 
 
Reagents and conditions: a) NaBH4, NaOAc, MeOH, H2O, 0°C; b) DMAP, 4-toluenesulfonyl chloride, 
CH2Cl2; c) NaCN, DMSO, reflux; d) NaOH, EtOH/H2O 1:2; e) N-methylaniline, DCC, DMAP, CH2Cl2, rt; 
f) Lawesson reagent, toluene, reflux; g) COCl2, toluene, CH2Cl2, DMF, 0°C; h) DABCO, THF, rt; i) NaN3, 
DMF/THF 2:1, rt. 
 
In the IR spectrum (neat), the new azirine (9) shows a characteristic C=N absorption at 1760 cm–1, and 
indicative signals for C(2) and C(3) appear in the 13C-NMR spectrum at 161.1 and 44.7 ppm, respectively. 
The CI-MS of 9 shows the base peak at m/z 219 ([M+1]+). 
A characteristic reaction of 2H-azirin-3-amines is that with thiobenzoic acid.25,26 In the present case, 
addition of 1.2 equiv. of thiobenzoic acid to a solution of 9 in dichloromethane at 0°C and stirring of the 
mixture at room temperature for 18 h, followed by chromatographic workup, gave the racemic 
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 monothiodiamide (15) in 90% yield (Scheme 2). This reaction is a chemical proof for the azirine structure, 
i.e., it shows that 9 is a synthon for 3-aminothiolane-3-carboxylic acid (3, Atc). 
Scheme 2 
 
 
 
To examine the use of this new 2H-azirin-3-amine as a building block in peptide synthesis, reactions of 9 
were carried out with Z-Val-OH and Fmoc-Val-OH. For this purpose, a mixture of 9 and 1.1 equiv. of the 
N-protected valine in dichloromethane was stirred at room temperature for 21 h. Chromatographic 
separation of the mixture obtained with Z-Val-OH (SiO2, ethyl acetate/hexane) gave two diastereoisomeric 
dipeptides Z-Val-Atc-N(Me)Ph (16a and 16b, Scheme 3) in 42 and 41% yield and a mixed fraction of the 
diastereoisomers (13%). The faster moving diastereoisomer (16a) with an Rf-value of 0.29 showed a mp of 
175–177°C, whereas the mp of the second isomer (16b) with Rf = 0.23 was 76–79°C.35 
 
Scheme 3 
 
 
 
A similar result was obtained in the reaction of 9 with Fmoc-Val-OH: the two diastereoisomers 17a and 17b 
were isolated in 45 and 22% yield, respectively, along with a mixed fraction in 32% yield. Again, the faster 
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 moving isomer (17a) showed the higher mp (194–196°C) in comparison with a broad ‘melting interval’ 
100–110°C for 17b. 
With the aim of demonstrating the usefulness of the reaction described above for peptide synthesis, the 
dipeptide 17a was selectively deprotected at the N- as well as the C-terminus. Heating of 17a in a 1:1 
mixture of aqueous 6N HCl and acetonitrile under reflux for 3 h gave the corresponding acid 18a in 89% 
yield (Scheme 4). On the other hand, the amino group of 17a was deprotected by treatment with 
diethylamine, leading to 19a in 78% yield. 
 
Scheme 4 
 
 
 
CONCLUSIONS 
We have shown that the novel 2H-azirin-3-amine (9) can be prepared in a multi-step synthesis via 
thioamide 14. The crucial formation of the three-membered ring was achieved via a modified protocol of 
the Rens and Ghosez procedure by successive treatment of 14 with phosgene, DABCO, and sodium azide. 
The model reaction of 9 with a N-protected valine derivative, e.g., Fmoc-Val-OH, successful separation 
the diastereoisomeric protected dipeptides, and the selective deprotection of the N- as well as the 
C-terminus demonstrate convincingly that the heterospirocyclic azirine (9) is a useful building block for 
peptide synthesis. 
 
EXPERIMENTAL 
 
General remarks. TLC: silica gel 60 F254 plates (0.25 mm, Merck). Prep. TLC: silica gel 60 F254 plates 
(2 mm, Merck). Column chromatography (CC): silica gel 60 (0.043–0.063 mm, Merck). Melting points: 
Büchi B-510 apparatus, uncorrected. IR spectra: Perkin-Elmer-Spektrum ONE FT-IR, in KBr or as film; 
in cm–1. 1H-NMR (300 MHz) and 13C-NMR (75 MHz) spectra: Bruker AVX-300 and ARX-300 
instrument, in CDCl3; chemical shifts in ppm, coupling constants J in Hz. CI-MS: Finnigan MAT-95 
instrument; NH3 as carrier gas. ESI-MS: Finnigan TSQ-700 (API). 
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 Synthesis of N-Methyl-N-phenyl-5-thia-1-azaspiro[2.4]hept-1-en-2-amine (9). 3-Hydroxythiolane.36 
To a solution of 3-oxothiolane (10) (11.6 mL, 14.0 g, 0.137 mol) in methanol (140 mL) in an ice bath, 
NaBH4 (11.1 g, 0.293 mol) and AcONa (23.5 g, 0.286 mol) in water (85 mL) were slowly added (70 min). 
After stirring for another 45 min at 0°C, the mixture was neutralized with conc. H2SO4 (8 mL) and then 
extracted with Et2O (5×). The combined organic phases were dried with MgSO4, filtered, the solvent was 
evaporated, and the white precipitate was filtered. Addition of CH2Cl2 led to the formation of additional 
precipitate. Filtration and bulb-to-bulb destillation (90°C, 8 mbar) gave 12.86 g (90%) of 
3-hydroxythiolane as colorless oil. Rf (SiO2, AcOEt/hexane 1:1) = 0.34 (UV254 and Ce(SO4)2).  IR (neat): 
3375vs, 2936vs, 1709m, 1427s, 1332s, 1311s, 1263s, 1196vs, 1140m, 1064s, 1026vs, 954vs, 886w, 831m, 
687s, 645s. 1H-NMR (CDCl3): 4.64–4.60 (m, H-C(3)); 3.03–2.80 (m, 4H, CH2(2), CH2(5)); 2.20–2.10 (m, 
1H of CH2(4)); 1.93–1.81 (m, 1H of CH2(4)). 13C-NMR (CDCl3): 74.4 (d, C(3)); 39.6, 37.9 (2t, C(2), 
C(5)); 28.1 (t, C(4)). CI-MS: 122 (100, [M+NH4]+), 105 (13, [M+H]+), 104 (5, M+•), 86 (25, [M–H2O]+). 
 
3-(4-Toluenesulfonyloxy)thiolane.37 To a solution of 3-hydroxythiolan (8.89 g, 85.34 mmol) in abs. 
CH2Cl2 (150 mL) at 0°C were added 4-(dimethylamino)pyridine (DMAP) (20.85 g, 170.6 mmol) and 
p-toluenesulfonyl chloride (16.27 g, 85.32 mmol), the mixture was stirred for 20 h at rt, and washed with 
1N HCl (30 mL). The aqueous phase was extracted with CH2Cl2 (40 mL, 3×). The combined organic 
phase was washed with sat. aqueous NaCl solution, dried with MgSO4, and the solvent evaporated to give 
26 g of crude product. Purification by column chromatography (SiO2, hexane/AcOEt 10:1 → 1:1, 2×) 
yielded 19.87 g (90 %) of 3-(4-toluenesulfonyloxy)thiolane as colorless crystals; mp 58–60°C. Rf (SiO2, 
hexane/AcOEt 5:1) = 0.19 (UV254 and Ce(SO4)2). IR (KBr): 3052vw, 2965w, 1913vw, 1642vw, 1595m, 
1492w, 1431m, 1361vs, 1337vs, 1316s, 1304m, 1292m, 1237m, 1197s, 1172vs, 1092s, 1048w, 1018w, 
1007m, 971m, 926vs, 891vs, 857s, 833m, 808s, 715vs, 667vs, 629vs. 1H-NMR (CDCl3): 7.82–7.78 (m, 2 
arom. H); 7.37–7.34 (m, 2 arom. H); 5.23–5.18 (m, H-C(3)); 3.03–2.81 (m, 4H, CH2(2), CH2(5)); 2.45 (s, 
3H, Me); 2.35–2.25 (m, 1H of CH2(4)); 2.04–1.89 (m, 1H of CH2(4)). 13C-NMR (CDCl3): 144.8, 133.9 
(2s, 2 arom. C); 129.8, 127.6 (2d, 4 arom. C); 83.6 (d, C(3)); 36.42, 36.38 (2t, C(2), C(5)); 27.9 (t, C(4)); 
21.5 (q, Me). CI-MS: 276 (100, [M+NH4]+), 104 (4, [M–Ts+1]+), 86 (10, [M–TsOH]+). Anal. Calcd for 
C11H14O3S2: C, 51.14; H, 5.46; S, 24.82. Found: C, 50.88; H, 5.24; S, 24.70. 
 
Thiolane-3-carbonitrile (11).38 To a solution of 3-(4-toluenesulfonyloxy)thiolane (10.34 g, 40.0 mmol) in 
DMSO (200 mL) was added NaCN (9.8 g, 200 mmol), the mixture was heated to reflux for 8 h, and 
stirred for another 20 h at rt. Then, the mixture was poured into water (700 mL), extracted with Et2O (300 
mL, 4×), and the combined Et2O phase was extracted with sat. aqueous NaCl solution, dried with MgSO4, 
and the solvent evaporated. Yield: 3.461 g of crude 11. Chromatographic purification (SiO2, 
 hexane/AcOEt 10:1 → 5:1) gave 2.48 g (55%) 11 as colorless oil; bp 105°C/8 mbar. Rf (SiO2, 
hexane/AcOEt 5:1) = 0.23 (UV254 and Ce(SO4)2). IR (neat): 3635w, 2941s, 2866m, 2240s, 1621w, 1439s, 
1333w, 1303m, 1252m, 1226m, 1184w, 1126w, 1080w, 1041w, 1013w, 955m, 930w, 889m, 813w, 743w, 
711w, 686w. 1H-NMR (CDCl3): 3.21–2.91 (m, 5H, CH2(2), CH(3), CH2(5)); 2.40–2.22 (m, 2H, CH2(4)). 
13C-NMR (CDCl3): 119.9 (s, CN); 34.9, 34.3 (2t, C(2), C(5)); 32.7 (d, C(3)); 29.9 (t, C(4)). CI-MS: 227 
(20, [2M+H]+), 170 (11), 154 (6), 131 (9), 114 (100, [M+H]+), 86 (5, [M–HCN]+). Anal. Calcd for 
C5H7NS: C, 53.06; H, 6.23; N, 12.38; S, 28.33. Found: C, 53.14; H, 6.04; N, 12.47; S, 28.31. 
 
Thiolane-3-carboxylic acid (12).39 Thiolane-3-carbonitrile (11) (2.499 g, 22.08 mmol) was dissolved in 
EtOH and added to a solution of NaOH (9.189 g, 229.72 mmol) in water (85 mL) and EtOH (43 mL). The 
mixture was heated to reflux for 2.75 h, then cooled to 0°C, and acidified with conc. HCl (28 mL). 
Ethanol was removed by distillation, and the remaining solution was extracted with CH2Cl2 (5×), dried 
with MgSO4, and evaporated to dryness to give 2.858 g (98%) of 12 as pale pink crystals; mp 61–62°C. 
Rf (SiO2, acetone/5 drops of AcOH) =  0.52 (Ce(SO4)2). IR (KBr): 2937s, 1699vs, 1422vs, 1350m, 1281s, 
1245vs, 1197s, 1091m, 1061w, 1013w, 940s, 893m, 879m, 824w, 736w, 687w, 652w. 1H-NMR (CDCl3): 
10.43 (br. s, OH); 3.75–2.87 (m, 5H, CH2(2), CH(3), CH2(5)); 2.33–2.23 (m, 2H, CH2(4)). 13C-NMR 
(CDCl3): 179.3 (s, COOH); 47.9 (d, C(3)); 33.6, 33.1 (2t, C(2), C(5)); 30.5 (t, C(4)). CI-MS: 133 (100, 
[M+H]+), 132 (46, M+•), 131 (10), 116 (3), 115 (62, [M–OH]+), 87 (12, [M–CO2H]+), 86 (9), 85 (7). Anal. 
Calcd for C5H8O2S: C, 45.43; H, 6.10; S, 24.26. Found: C, 45.44; H, 5.84; S, 24.09. 
 
N-Methyl-N-phenylthiolane-3-carboxamide (13). To a solution of the carboxylic acid (12) (2.84 g, 21.49 
mmol) in CH2Cl2 (45 mL) was added DCC (4.88 g, 23.65 mmol). Immediately, a white precipitate 
formed, and the mixture got warm. Then, N-methylaniline (4.61 g, 42.99 mmol) and DMAP (0.26 g, 2.13 
mmol) were added and the mixture stirred for 17.5 h at rt. The precipitate was filtered, the filtrate 
concentrated, and the residue dissolved in AcOEt (60 mL). The solution was extracted successively with 
1N HCl (3×), with sat. aqueous NaHCO3 solution (1×), and with sat. aqueous NaCl solution (1×), dried 
with MgSO4, and evaporated. Purification by column chromatography (2×, SiO2, hexane/AcOEt 5:1) 
gave 3.96 g (83%) of amide (13). Colorless crystals; mp 63–64°C. Rf (hexane/AcOEt 1:1) = 0.43 (UV254). 
IR (KBr): 2934m, 2860w, 1654vs, 1592s, 1494s, 1426s, 1387s, 1331m, 1295s, 1260m, 1204w, 1122s, 
1071w, 1024w, 997w, 892w, 845vw, 777m, 750w, 701s, 659w, 571m. 1H-NMR (CDCl3): 7.47–7.35 (m, 3 
arom. H); 7.22–7.18 (m, 2 arom. H); 3.28 (s, 3H, Me); 3.07–2.59 (m, 5H, CH2(2), CH(3), CH2(5)); 
2.19–2.10 (m, 2H, CH2(4)). 13C-NMR (CDCl3): 172.6 (s, CO); 143.6 (s, 1 arom. C); 129.9, 128.0, 127.1 
(3d, 5 arom. CH); 46.2 (d, C(3)); 37.6 (q, Me); 35.1, 34.6 (2t, C(2), C(5)); 31.0 (t, C(4)). ESI-MS: 260 (4, 
[M+K]+), 244 (100, [M+Na]+). Anal. Calcd for C12H15NOS: C, 65.12; H, 6.83; N, 6.33; S, 14.49. Found: 
 C, 65.25; H, 6.54; N, 6.17; S, 14.41. 
 
N-Methyl-N-phenylthiolane-3-thiocarboxamide (14). To a solution of amide (13) (6.12 g, 27.65 mmol) in 
toluene (28 mL) was added Lawesson reagent (6.71 g, 16.59 mmol) and the mixture heated to 130°C. 
After 1 h, the mixture was cooled to rt, filtered, washed with Et2O, and evaporated. Purification by 
column chromatography (hexane/AcOEt 10:1) yielded 6.28 g (96%) of thioamide (14). Pale yellow 
crystals; mp 74–76°C. Rf (hexane/AcOEt 5:1) = 0.32 (UV254 and Schlittler). IR (KBr): 2927m, 2857w, 
1590m, 1582m, 1489vs, 1450vs, 1434vs, 1381vs, 1330s, 1281s, 1215m, 1191s, 1100s, 1068s, 1020m, 
993m, 971m, 886w, 801w, 767s, 700vs, 615w, 558s. 1H-NMR (CDCl3): 7.52–7.40 (m, 3 arom. H); 
7.19–7.16 (m, 2 arom. H); 3.73 (s, 3H, Me); 3.31 (t, J = 10.1 Hz, 1H); 3.11–3.02 (m, 1H); 2.96–2.90 (m, 
1H); 2.79–2.73 (m, 1H); 2.66–2.57 (m, 1H); 2.47–2.36 (m, 1H); 2.17–2.12 (m, 1H). 13C-NMR (CDCl3): 
205.8 (s, CS); 145.3 (s, 1 arom. C); 130.2, 128.7, 125.3 (3d, 5 arom. CH); 53.2 (d, C(3)); 45.8 (q, Me); 
39.1, 38.2 (2t, C(2), C(5)); 30.8 (t, C(4)). CI-MS: 240 (9), 239 (15), 238 (100, [M+H]+), 237 (4, M+•). 
Anal. Calcd for C12H15NS2: C, 60.72; H, 6.37; N, 5.90; S, 27.01. Found: C, 60.50; H, 6.12; N, 5.80; S, 
27.06. 
 
N-Methyl-N-phenyl-5-thia-1-azaspiro[2.4]hept-1-en-2-amine (9). To a solution of thioamide (14) (2.011 
g, 8.47 mmol) in abs. CH2Cl2 (14 mL) were added 5 drops of DMF. Under an argon atmosphere at 0°C, a 
2M solution of phosgene in toluene (5.5 mL, 11.01 mmol) was added dropwise within 5 min, and the 
mixture was stirred for 30 min. Then, the evolution of CO2 ceased, the solvent was evaporated, and the 
residue was dissolved in abs. THF (10 mL). Still at 0°C, DABCO (0.965 g, 8.60 mmol) was added and 
the mixture stirred for 20 min. In a N2 atmosphere, the precipitated salt was removed by filtration, washed 
with DMF (10 mL), and to the filtrate was added NaN3 (1.159 g, 17.83 mmol). The mixture was stirred at 
rt for 6 d, filtered via Celite, and washed with Et2O. Column chromatography (hexane/AcOEt 5:1) gave 9, 
contaminated with 5% (1H-NMR) of 13, as brownish, viscose oil: 1.379 g (i.e. 1.29 g of 9, 70% yield; 
corrected on the basis of the 1H-NMR spectrum). Rf (hexane/AcOEt 2:1) = 0.28 (UV254 and Ce(SO4)2). IR 
(neat): 3460w, 3062m, 3045m, 2918s, 1760vs, 1675s, 1653s1598vs, 1501vs, 1457s, 1425s, 1409s, 1387m, 
1321vs, 1303s, 1281s, 1259s, 1224s, 1207s, 1188m, 1159m, 1110vs, 1096vs, 1033s, 1003s, 980m, 965m, 
894m, 842w, 755vs, 692vs, 662s, 620w. 1H-NMR (CDCl3): 7.44–7.37 (m, 3 arom. H); 7.21–7.10 (m, 2 
arom. H); 3.48 (s, 3H, Me); 3.21–3.12 (m, 1 H of CH2(6)); 3.02 (d, 2J = 12.1 Hz, 1H of CH2(4)); 
2.96–2.87 (m, 1H of CH2(6)); 2.71 (d, 2J = 12.1 Hz, 1H of CH2(4)); 2.27 – 2.17 (m, 1 H of CH2(7)); 
2.00–1.92 (m, 1 H of CH2(7)). 13C-NMR (75.5 MHz, CDCl3): 161.0 (s, C(2)); 142.0 (s, 1 arom. C); 129.4, 
123.5, 116.1 (3d, 5 arom. CH); ca. 53 (br., C(3)); 38.2, 37.3 (2t, 2 CH2S); ca. 34 (br., Me); 29.5 (t, 
CH2(7)). CI-MS: 219 (100, [M+H]+), 218 (4, M+•), 217 (5). 
 Reaction of N-methyl-N-phenyl-5-thia-1-azaspiro[2.4]hept-1-en-2-amine (9) with thiobenzoic acid. 
N-{3-[(N-Methyl-N-phenylamino)thioxomethyl]thiolan-3-yl}benzamide (15). A solution of azirine (9) (68 
mg, 0.31 mmol) in abs. CH2Cl2 (3 mL) was cooled to 0°C. Then, thiobenzoic acid (58 mg, 0.42 mmol) 
was added dropwise and the mixture was stirred at rt. After 18 h, the solvent was evaporated and the 
product purified by prep. TLC (CH2Cl2/MeOH 50:1): 99.8 mg (90%) of 15 as colorless solid; mp 
170–172°C. Rf (hexane/AcOEt 1:1) = 0.42 (UV254 and Ce(SO4)2). IR (KBr): 3401m, 3059vw, 3034vw, 
2941w, 2869vw, 1667vs, 1580w, 1509vs, 1483vs, 1465s, 1452s, 1443s, 1433s, 1377vs, 1280s, 1257m, 
1234m, 1222m, 1198w, 1176w, 1131w, 1111s, 1073m, 1037m, 1001w, 988w, 924w, 845vw, 772m, 705vs, 
619w. 1H-NMR (CDCl3): 7.51–6.97 (m, 10 arom. H); 5.79 (br. s, NH); 3.73 (s, 3H, MeN); 3.49 (d, 2J = 
11.4 Hz, 1H of CH2(2)(Atc)); 3.40–3.29 (m, 1H); 3.12–3.05 (m, 1H); 2.98 (d, 2J = 11.4 Hz, 1H of 
CH2(2)(Atc)); 2.90–2.84 (m, 1H); 2.61–2.51 (m, 1H). 13C-NMR (CDCl3): 202.2 (s, CS); 165.8 (s, 
CONH); 147.1 (s, 1 arom. CN); 133.5 (s, 1 arom. C); 131.8, 129.8, 129.1, 128.4, 128.0, 126.8, 125.6, 
125.2 (8d, 10 arom. CH); 73.6 (s, C(3)(Atc)); 50.5 (q, Me); 43.1 (t, 2 CH2S); 28.0 (t, CH2(4)(Atc)). 
ESI-MS: 395 (7, [M+K]+), 379 (8, [M+Na]+), 357 (100, [M+H]+), 250 (22). Anal. Calcd for C19H20N2OS2: 
C, 64.01; H, 5.65; N, 7.86; S, 17.99. Found: C, 64.06; H, 5.50; N, 7.66; S, 17.75. 
 
Reaction of N-methyl-N-phenyl-5-thia-1-azaspiro[2.4]hept-1-en-2-amine (9) with Z-Val-OH. Benzyl 
N-[3-Methyl-(S)-2-((R,S)-3-{[(N-methyl-N-phenylamino)carbonyl]thiolan-3-yl}amino)-1-oxobutyl]carb-
amate (Z-Val-Atc-N(Me)Ph (16)). To a solution of azirine (9) (377 mg, 1.73 mmol) in abs. CH2Cl2 (10 
mL) at 0°C, a solution of Z-Val-OH (514 mg, 2.05 mmol) in abs. CH2Cl2 (8 mL) was added slowly. The 
mixture was stirred at rt for 21 h and the solvent was evaporated. Column chromatography of the residue 
(SiO2, hexane/AcOEt 5:1 → 2:1) gave 772 mg (95%) of 16 in three fractions: 339 mg (42%) of the faster 
moving diastereoisomer 16a (Rf (hexane/AcOEt 1:1) = 0.29 (UV254 and Ce(SO4)2), 101 mg (13%) of a 
mixture of the two diasteroisomers, and 332 mg (41%) of the slower moving diastereoisomer 16b (Rf 
(hexane/AcOEt 1:1) = 0.23 (UV254 and Ce(SO4)2). 
Diastereoisomer 16a: Colorless crystals; mp 175–177°C. IR (KBr): 3364s, 3267vs, 3061w, 3026w, 
2958m, 1715vs, 1652vs, 1595m, 1538vs, 1507vs, 1436s, 1389s, 1310w, 1264s, 1237vs, 1161w, 1129w, 
1100s, 1024m, 1006m, 971w, 859w, 778w, 769w, 742m, 701s, 653m. 1H-NMR (CDCl3): 7.43–729 (m, 8 
arom. H); 7.08–7.05 (m, 2 arom. H); 5.52 (d, 3J = 6.7 Hz, NH(Val)); 5.29 – 5.10 (m, NH(Atc)); 5.21, 5.13 
(AB, J = 12.3 Hz, 2H, CH2O); 3.64–3.60 (m, H-C(2)(Val)); 3.22 (s, 3H, MeN); 3.18 (d, 2J = 11.6 Hz, 1H 
of CH2(2)(Atc)); 2.89–2.63 (m, 4H, 2 CH2); 2.56–2.49 (m, 1H of CH2(2)(Atc)); 1.90–1.84 (m, 
H-C(3)(Val)); 0.89 (d, 3J = 6.8 Hz, 3H, Me); 0.80 (d, 3J = 6.8 Hz, 3H, Me). 13C-NMR (CDCl3): 170.2, 
168.4 (2s, 2 CO); 156.1 (s, OCONH); 143.6 (s, 1 arom. CN); 136.4 (s, 1 arom. C); 129.6, 128.4, 128.1, 
128.0, 127.3 (5d, 10 arom. CH); 69.5 (s, C(3)(Atc)); 66.9 (t, CH2O); 59.2 (d, C(2)(Val)); 40.6 (q, MeN); 
 40.4, 38.5, 27.4 (3t, 3 CH2); 32.1 (d, C(3)(Val)); 19.1, 16.8 (2q, 2 Me). ESI-MS: 492 (100, [M+Na]+). 
Anal. Calcd for C25H31N3O4S: C, 63.94; H, 6.65; N, 8.95; S, 6.83. Found: C, 63.82; H, 6.41; N, 8.85; S, 
6.81. 
Diastereoisomer 16b: Colorless solid; mp 76–79°C. 1H-NMR (CDCl3): 7.36–7.27 (m, 8 arom. H); 
7.15–7.21 (m, 2 arom. H); 5.92 (br. s, NH(Atc)); 5.48 (d, 3J = 8.6 Hz, NH(Val)); 5.16, 5.09 (AB, J = 12.3 
Hz, CH2O); 3.78–3.74 (m, H-C(2)(Val)); 3.44 (d, 2J = 11.8 Hz, 1H of CH2(2)(Atc); 3.21 (s, 3H, MeN); 
2.94–2.80 (m, 2H); 2.65–2.56 (m, 1H); 2.50–2.31 (m, 2H); 2.19–2.08 (m, 1H); 0.93 (d, 2J = 6.8 Hz, 3H, 
Me); 0.85 (d, 2J = 6.8 Hz, 3H, Me). 13C-NMR (CDCl3): 170.6, 169.2 (2s, 2 CO); 156.2 (s, OCONH); 
143.9 (s, 1 arom. CN); 136.2 (s, 1 arom. C); 129.4, 128.4, 128.2, 128.0, 127.9, 127.3 (6d, 10 arom. CH); 
69.5 (s, C(3)(Atc)); 67.0 (t, CH2O); 59.7 (d, C(2)(Val)); 40.6 (q, MeN); 39.9, 39.4, 28.1 (3t, 3 CH2); 30.8 
(d, C(3)(Val)); 19.2, 17.1 (2q, 2 Me). ESI-MS: 492 (100, [M+Na]+). Anal. Calcd for C25H31N3O4S: C, 
63.94; H, 6.65; N, 8.95; S, 6.83. Found: C, 63.87; H, 6.57; N, 8.81; S, 6.88. 
 
Reaction of N-methyl-N-phenyl-5-thia-1-azaspiro[2.4]hept-1-en-2-amine (9) with FMOC-Val-OH. 
[(9H-Fluoren-9-yl)methyl] N-[3-methyl-(S)-2-((R,S)-3-({[(N-methyl-N-phenylamino)carbonyl]thiolan- 
3-yl}amino)-1-oxobutyl]carbamate (Fmoc-Val-Atc-N(Me)Ph (17)). To a solution of 9 (467 mg, 2.14 
mmol) in abs. CH2Cl2 (15 mL) at 0°C, Fmoc-Val-OH (855 mg, 2.52 mmol) was added and the mixture 
stirred for 21 h at rt. Then, the solvent was evaporated, and the residue separated by column 
chromatography (SiO2, hexane/AcOEt 5:1 → 2:1) to give 1.18 g (99%) 17 in three fractions: 537 mg 
(45%) of the faster moving diastereoisomer 17a (Rf (hexane/AcOEt 1:1) = 0.28 (UV254 and Ce(SO4)2), 
378 mg (32%) of a mixture of the two diastereoisomers, and 265 mg (22%) of the slower moving 
diastereoisomer 17b (Rf (hexane/AcOEt 1:1) = 0.22 (UV254 and Ce(SO4)2). 
Diastereoisomer 17a: Colorless solid; mp 194–196°C. IR (KBr): 3351m, 3273s, 2961w, 2935w, 1720vs, 
1661vs, 1633vs, 1595m, 1537s, 1515s, 1495s, 1450s, 1389m, 1257s, 1227s, 1170w, 1134w, 1103w, 
1030m, 973vw, 758m, 738s, 702m, 649w, 621w. 1H-NMR (CDCl3): 7.77 (d, 3J = 7.5 Hz, 2 arom. H); 7.64 
(t, 3J = 6.7 Hz, 2 arom. H); 7.58–7.29 (m, 7 arom. H); 7.10–7.08 (m, 2 arom. H); 5.55 (d, 3J = 8.8 Hz, 
NH(Val)); 5.22 (br. s, NH(Atc)); 4.53–4.42 (m, 2H, CH2O); 4.27 (t, 3J = 6.9 Hz, H-C(9) of fluorene); 
3.66–3.62 (m, H-C(2)(Val)); 3.25 (s, 3H, MeN); 3.18 (d, 2J = 11.6 Hz, 1 H (Atc)); 2.91–2.48 (m, 5H 
(Atc)); 1.90–1.84 (m, H-C(3)(Val)); 0.89 (d, 3J = 6.7 Hz, 3H, Me); 0.81 (d, 3J = 6.7 Hz, 3H, Me). 
13C-NMR (CDCl3): 170.2, 168.4 (2s, 2 CO); 156.0 (s, OCONH); 143.7, 141.3, 129.6 (3s, 5 arom. C); 
128.2, 127.7, 127.3, 127.0, 125.0, 124.9, 120.0 (7d, 13 arom. CH); 69.6 (s, C(3)(Atc)); 66.9 (t, CH2O); 
59.2 (d, C(2)(Val)); 47.6 (d, C(9) of fluorene); 40.6 (q, MeN); 40.4, 38.5, 27.4 (3t, 3 CH2(Atc)); 32.2 (d, 
C(3)(Val)); 19.1, 16.9 (2q, 2 Me). ESI-MS: 596 (3, [M+K]+), 580 (100, [M+Na]+). Anal. Calcd for 
C32H35O4N3S: C, 68.91; H, 6.33; N, 7.53; S, 5.75. Found: C, 68.68; H, 6.16; N, 7.39; S, 5.51. 
 Diastereoisomer 17b: Colorless solid; mp ca. 100–110°C. 1H-NMR (CDCl3): 7.77 (d, 3J = 7.5 Hz, 2 arom. 
H); 7.62–7.56 (m, 2 arom. H); 7.40 (t, 3J = 7.1 Hz, 2 arom. H); 7.33–7.21 (m, 5 arom. H); 7.14 (d, 3J = 7.1 
Hz, 2 arom. H); 5.70 (br. s, NH(Atc)); 5.32 (d, 3J = 9.2 Hz, NH(Val)); 4.44 (d, 3J = 7.0, CH2O); 4.23 (t, 3J 
= 6.8 Hz, H-C(9) of fluorene); 3.73 (br. s, H-C(2)(Val)); 3.47 (d, 2J = 11.8 Hz, 1H(Atc)); 3.24 (s, 3H, 
MeN); 2.98–2.82 (m, 2H(Atc)); 2.64–2.55 (m, 1H(Atc)); 2.48–2.31 (m, 2H(Atc)); 2.15–2.05 (m, 
H-C(3)(Val)); 0.91 (d, 3J = 6.3 Hz, Me); 0.83 (d, 3J = 6.5 Hz, 3H, Me). 13C-NMR (CDCl3): 170.5, 169.1 
(2s, 2 CO); 156.2 (s, OCONH); 143.9, 143.6, 141.3 (3s, 5 arom. C); 129.5, 128.0, 127.7, 127.3, 127.0, 
124.9, 124.8, 120.0 (8d, 13 arom. CH); 69.6 (s, C(3)(Atc)); 66.9 (t, CH2O); 59.6 (d, C(2)(Val)); 47.1 (d, 
C(9) of fluorene); 40.7 (q, MeN); 40.0, 39.4, 28.1 (3t, 3 CH2(Atc)); 30.7 (d, C(3)(Val)); 19.1, 17.1 (2q, 2 
Me). ESI-MS: 596(4, [M+K]+), 580 (100, [M+Na]+), 538 (8), 522 (3), 179 (10). Anal. Calcd for 
C32H35O4N3S: C, 68.91; H, 6.33; N, 7.53; S, 5.75. Found: C, 68.69; H, 6.33; N, 7.24; S, 5.53. 
 
Selective deprotection of dipeptide (17). (R,S)-3-{[(S)-2-({[(9H-Fluoren-9-yl)methoxy]carbonyl} 
amino)-3-methyl-1-oxobutyl]amino}thiolan-3-carboxylic acid (18a). To a mixture of MeCN (5 mL) and 
6N HCl (5 mL), 17a (0.369 g, 0.662 mmol) was added and the mixture stirred for 4 d at rt. After this time, 
no change could be detected. Then, the mixture was heated to reflux for 3 h, extracted with CH2Cl2 (20 
mL, 3×), the organic phase was dried with MgSO4, and the solvent evaporated. Yield of 17a: 0.309 g 
(89%). Colorless solid; mp ca. 95–105°C. Rf (acetone + 3 drops of AcOH) = 0.59 (UV254 and Ce(SO4)2). 
IR (KBr): 3310s, 3066m, 2963s, 2612w, 1716vs, 1660vs, 1538vs, 1477m, 1449s, 1392m, 1372m, 1320m, 
1246vs, 1186m, 1139w, 1106w, 1031m, 759s, 740s, 694vw, 665w, 621w. 1H-NMR (CDCl3): 7.72 (d, 3J = 
7.4 Hz, 2 arom. H); 7.55 (d, 3J = 7 Hz, 2 arom. H); 7.36 (m, 2 arom. H); 7.24 (m, 2 arom. H); 6.44 (br. s, 
NH); 5.94 (br. s, NH); 4.41–4.32 (m, 2H, CH2O); 4.20–4.15 (m, H-C(9) of fluorene); 3.21–3.18 (m, 
H-C(2)(Val)); 2.92–2.64 (m, 4H, 2 CH2(Atc)); 2.44–2.34 (m, H-C(3)(Val)); 2.14–2.04 (m, 2H, CH2(Atc)); 
0.95–0.90 (m, 6H, 2 Me). 13C-NMR (CDCl3): 175.8, 172.4 (2s, 2 CO); 156.9 (s, OCONH); 143.7, 143.5, 
141.2 (3s, 4 arom. C); 127.6, 127.0, 125.0, 119.9 (4d, 8 arom. CH); 68.3 (s, C(3)(Atc)); 67.3 (t, CH2O); 
60.0 (d, C(2)(Val); 47.0 (d, C(9) of fluorene); 39.3, 37.5, 28.7 (3t, 3 CH2(Atc)); 31.1 (d, C(3)(Val)); 20.6, 
17.5 (2q, 2 Me). ESI-MS: 507 (10, [M+K]+), 491 (100, [M+Na]+), 362 (4), 179 (8). Anal. Calcd for 
C25H28N2O5S·H2O: C, 61.71; H, 6.21; N, 5.76; S, 6.59. Found: C, 61.59; H, 5.96; N, 5.36; S, 5.48. 
 
{3-[((S)-2-Amino-3-methyl-1-oxobutyl)amino]thiolan-3-yl}-N-methyl-N-phenylcarboxamide (19). 240 mg 
(0.430 mmol) of 17b were dissolved in Et2NH (5 mL), and the mixture was stirred at rt for 100 min. Then, 
the solvent was evaporated, the residue dissolved in CH2Cl2 and purified by prep. TLC. Yield of 17b: 112 
mg (78%). Colorless solid; mp ca. 50–55°C. Rf (hexane/AcOEt 1:4) = 0.22 (UV254 and Ce(SO4)2). IR 
(KBr): 3314s, 3058m, 2959vs, 2870s, 1651vs, 1592vs, 1494vs, 1453s, 1369vs, 1291s, 1247m, 1222m, 
 1172w, 1127m, 1073m, 1025w, 997vw, 961w, 871w, 846w, 775m, 734m, 703s, 666m, 615w. 1H-NMR 
(CDCl3): 7.42–7.30 (m, 3 arom. H); 7.28–7.21 (m, 2 arom. H); 3.28 (s, 3H, MeN); 3.25–3.21 (m, 2H); 
2.95–2.70 (m, 6H); 2.62–2.56 (m, 1H); 2.23–2.04 (m, 1H); 1.43 (br. s, 1 H); 0.92 (d, 3J = 6.9 Hz, 3H, 
Me); 0.74 (d, 3J = 6.9 Hz, 3H, Me). 13C-NMR (CDCl3): 173.2, 169.1 (2s, 2 CO); 144.6 (s, 1 arom. C); 
129.2, 127.6, 127.0 (3d, 5 arom. CH); 68.9 (s, C(3)(Atc)); 59.7 (d, C(2)(Val)); 40.9 (q, MeN); 40.7, 38.9, 
27.7 (3t, 3 CH2(Atc)); 30.5 (d, C(3)(Val)); 19.5, 16.1 (2q, 2 Me). ESI-MS: 693 (10, [2M+Na]+), 671 (7, 
[2M+H]+), 358 (27, [M+Na]+), 336 (100, [M+H]+), 229 (32), 201 (13). 
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